Full-Time

Lab Trainer

Posted on 9/13/2025

Zeiss

Zeiss

1,001-5,000 employees

Manufactures high-precision optical instruments and devices

No salary listed

Toronto, ON, Canada

In Person

Category
Training
Requirements
  • High school diploma or equivalent (required).
  • Previous experience in training roles; trainer certification is preferred.
  • 2+ years of experience in the optical industry with a focus on optical edging, mounting, and inspection.
  • Language Skills: Fluent in English with the ability to communicate clearly and concisely.
  • Technical Proficiency: Skilled in Microsoft Office tools, including Outlook, Excel, PowerPoint, and Word.
  • Optical Expertise: Comprehensive knowledge of optical mounting, inspection processes, and equipment calibration.
  • Teaching Skills: Familiarity with effective teaching methodologies, tools, and techniques.
  • Organizational Skills: Strong organizational and time management abilities.
  • Critical Thinking: Demonstrated critical thinking and decision-making capabilities.
  • Analytical Skills: Strong analytical and problem-solving skills are essential.
  • Performance Management: Experience in monitoring and improving employee performance.
  • Self-Motivation: Highly organized and self-driven, with the ability to take initiative.
  • Adaptability: Flexible and capable of performing a variety of tasks.
  • Work Environment: Ability to thrive in a fast-paced, multi-tasking production environment.
  • Focus and Precision: Capacity to maintain focus for extended periods, with a keen eye for detail and symmetry.
  • Patience and Persistence: Must possess the patience to see tasks through to completion.
  • Integrity: Honest, dependable, and able to follow both written and verbal instructions.
  • Professionalism: Maintains a professional demeanor, including in customer-facing interactions.
  • Work Schedule Flexibility: Willingness to work overtime and off-shift hours as needed.
  • Mechanical Skills: Strong dexterity and mechanical aptitude.
  • Manufacturing Experience: Prior experience in manufacturing operations is preferred.
Responsibilities
  • Define and communicate lab-wide training goals to leadership and team members, with a specific focus on Cut, Edge and Fit (CEF) operations.
  • Address quality concerns by collaborating with internal and external customers, particularly in areas relating to CEF processes.
  • Develop and oversee training initiatives within operations, including the creation of necessary training materials.
  • Plan, implement, monitor, and communicate the Training Schedule, setting clear expectations.
  • Lead individual and group training sessions, including: Classroom Training: Covering work instructions and hands-on activities specific to CEF processes. Shop Floor Training: Demonstrating and supervising hands-on tasks related to CEF operations.
  • Use reports to evaluate the effectiveness of training programs, particularly in improving performance in CEF areas.
  • Administer written exams post-training to understand retention.
  • Benchmark results against like facilities in the network.
  • Adapt training programs to align with learning patterns and performance goals.
  • Conduct skill assessments for associates to evaluate proficiency.
  • Maintain accurate training records for all associates.
  • Oversee the skills certification process for associates.
  • Plan and revise future training programs based on operational needs.
  • Support management in reviewing, updating, and implementing work instructions, ensuring changes are incorporated into training plans.
  • Keep the training area and personal workspace clean and organized.
  • Participate in internal operator calibration and external self-calibration activities.
  • Contribute to the CEF Training Network and drive continuous improvement of the training program and methodology.
  • Adhere to safety standards and promptly report any safety concerns to leadership.
  • Other duties as assigned.
Desired Qualifications
  • Trainer certification is preferred.
  • Manufacturing Experience preferred.

ZEISS is a global leader in optics and optoelectronics, serving medical professionals, industrial manufacturers, consumers, and the semiconductor industry. It designs and sells high-precision optical instruments, medical devices, semiconductor manufacturing equipment, and vision care products such as corrective lenses and eye-health services. Its products rely on advanced optics and imaging technologies to deliver accurate inspection, diagnosis, and manufacturing outcomes across healthcare, industrial quality control, consumer optics, and chip fabrication. What sets ZEISS apart is its breadth and depth: a long-standing scale in multiple markets, integrated solutions across optics, imaging, metrology, and precision engineering, and a commitment to sustainability in electricity use and carbon emissions. The company’s goal is to advance optics and optoelectronics by providing reliable, high-quality tools and services worldwide while operating in a sustainable way.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$1.1B

Headquarters

Oberkochen, Germany

Founded

2001

Simplify Jobs

Simplify's Take

What believers are saying

  • NMPA approval accelerates ARTEVO 750/850 sales in China's ophthalmic market.
  • Collaborative Care app boosts data sharing, capturing digital health interoperability growth.
  • CALYPSO 2024 software upgrade generates recurring revenue from CMM customers.

What critics are saying

  • TSMC and Samsung capex cuts collapse Semiconductor Manufacturing Technology revenue.
  • Suoer and Kangyang erode ARTEVO pricing in saturated Chinese microscope market.
  • CLINIC 360 FDA delays stall AI diagnostic platform commercialization.

What makes Zeiss unique

  • ZEISS leads in AI-powered ophthalmic tools like VisioGen and ARTEVO microscopes.
  • Balanced revenue across semiconductor, medical, industrial, and consumer optics segments.
  • 175-year legacy drives precision innovations in four global business segments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Company News

PR Newswire
Apr 2nd, 2026
ZEISS unveils AI-powered patient platform and enhanced IOL tools at ASCRS

ZEISS has unveiled new digital, AI and surgical innovations for cataract and refractive workflows at the ASCRS conference. The medical technology company is expanding its US cataract portfolio with new irrigation/aspiration handpieces compatible with the DORC EVA NEXUS surgical system, alongside enhanced IOL calculation capabilities for the ZEISS IOLMaster 700. ZEISS also launched VisioGen commercially in the US, a human-verified AI patient engagement platform for ophthalmology practices. The platform integrates with clinic websites to capture patient demand around the clock, with AI-assisted responses reviewed by ZEISS-trained optometrists before delivery. The company showcased ZEISS Collaborative Care, a cloud-based application enabling secure data sharing between eye care professionals, and previewed ZEISS CLINIC 360, pending FDA clearance. ZEISS is celebrating 100 years of US operations this year.

PR Newswire
Mar 24th, 2026
ZEISS expands ophthalmic portfolio in Canada with new diagnostic lasers and workflow tools

ZEISS Medical Technology has expanded its ophthalmic workflow portfolio in Canada with new diagnostic, visualisation and therapeutic solutions. The company will showcase the innovations at upcoming Canadian ophthalmology conferences in Ottawa and Montréal. Key additions include ICGA for ZEISS CLARUS 700, offering simultaneous FA and ICG capture for clinical assessment, and ZEISS VISULAS green with selective laser trabeculoplasty for retinal photocoagulation. The company has introduced refraction devices ZEISS VISUREF 600 and ZEISS VISUCORE 500 to streamline diagnostic workflows. ZEISS also launched VISULAS yag, a new-generation therapeutic laser for anterior segment photodisruption within cataract workflows. The ZEISS FORUM subscription package, now available in Canada, offers integrated data management with unlimited device licences and lower upfront costs.

PR Newswire
Feb 23rd, 2026
ZEISS launches Collaborative Care app for eye care professionals with cloud and on-premises options

ZEISS Medical Technology has launched Collaborative Care, a browser-based application enabling eye care professionals to share data securely, refer patients and coordinate clinical care. Built on the ZEISS Health Data Platform, the solution addresses fragmented data sharing and inefficient referral processes in ophthalmic care. The application offers flexible deployment as either a standalone cloud solution or an integrated extension of ZEISS FORUM. Key features include secure exchange of images and reports, streamlined referral workflows with tracking capabilities, and tools for building professional networks between optometrists and ophthalmologists. ZEISS Collaborative Care was demonstrated at industry events in London and Orlando in February and March 2026. The company generated €2,228 million in revenue in fiscal year 2024/25 with 5,784 employees worldwide.

Handelsblatt
Feb 19th, 2026
Custom Surgical raises $4M to develop AI-powered ophthalmology platform

Custom Surgical, a German ophthalmology company, has raised €3.5 million to advance its platform. The funding will support development of AI-powered features including automated image optimisation and assisted triage processes that help determine case urgency and specialist assignment. The company is already developing its first AI-based triage and screening system. The technology aims to provide initial assessments that guide decisions on how urgently cases need attention and which medical professionals should handle them next.

Investors Hangout
Feb 18th, 2026
Mindpeak raises $15.3M Series A to scale AI cancer diagnostic tools

Mindpeak, an AI-driven pathology startup, raised $15.3 million in a Series A round led by ZEISS Ventures and InnoVentureFund in 2024. The funding will accelerate development and deployment of the company's AI diagnostic tools for cancer pathology. Founded in 2018, Mindpeak's algorithms have supported over 30,000 patient diagnoses across US and European healthcare markets. The technology uses automated histological analyses to help pathologists make faster, more precise clinical decisions. CEO Felix Faber stated the capital would expedite product rollouts and expand capabilities. The company has established strategic partnerships with major players including Roche. Mindpeak operates in the rapidly growing digital pathology market, driven by technological innovation and increasing demand for advanced diagnostic services in an ageing population.

INACTIVE